Publications by authors named "Gerald DeNardo"

Claim this Profile
C
Concepts, consequences, and implications of theranosis.
Gerald L DeNardo, Sally J DeNardo

Semin Nucl Med· May 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pretherapy prediction of nephrotoxicity after peptide radionuclide receptor therapy (PRRT).
Gerald L Denardo, Daniel J Macey

Cancer Biother Radiopharm· October 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dose intensified molecular targeted radiotherapy for cancer-lymphoma as a paradigm.
Gerald DeNardo, Sally DeNardo

Semin Nucl Med· March 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Health care in the United States in 2009: both sides of the "counter".
Gerald L DeNardo, Sally J DeNardo

Cancer Biother Radiopharm· October 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hexa-arginine enhanced uptake and residualization of selective high affinity ligands by Raji lymphoma cells.
Rod Balhorn, Saphon Hok, Sally DeNardo, Arutselvan Natarajan, Gary Mirick, Gerald Denardo

Mol Cancer· April 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Update: Turning the heat on cancer.
Gerald L DeNardo, Sally J DeNardo

Cancer Biother Radiopharm· December 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nanomolecular HLA-DR10 antibody mimics: A potent system for molecular targeted therapy and imaging.
Gerald L DeNardo, Arutselvan Natarajan, Saphon Hok, Gary Mirick, Sally J DeNardo

Cancer Biother Radiopharm· December 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of TNKase-specific cleavable peptide-linked radioimmunoconjugates for radioimmunotherapy.
Arutselvan Natarajan, Pappanaicken R Kumaresan, Sally J Denardo, Gerald L Denardo, Gary Mirick

Bioorg Med Chem Lett· September 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular imaging/therapy: it's only useful if it's useful--and available.
Gerald DeNardo

J Nucl Med· September 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Systemic radiotherapy can cure lymphoma: a paradigm for other malignancies?
Gerald L DeNardo, Sally J DeNardo, Rod Balhorn

Cancer Biother Radiopharm· August 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeted radionuclide therapy.
Lawrence E Williams, Gerald L DeNardo, Ruby F Meredith

Med Phys· July 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Short communication: nanoparticle thermotherapy and external beam radiation therapy for human prostate cancer cells.
Joerg Lehmann, Arutselvan Natarajan, Gerald L Denardo, Robert Ivkov, Allan R Foreman, Sally J Denardo

Cancer Biother Radiopharm· April 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of multivalent radioimmunonanoparticles for cancer imaging and therapy.
Arutselvan Natarajan, Cheng-Yi Xiong, Cordula Gruettner, Gerald L DeNardo, Sally J DeNardo

Cancer Biother Radiopharm· February 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The conundrum of personalized cancer management, drug development, and economics.
Gerald L DeNardo

Cancer Biother Radiopharm· December 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characteristics of dimeric (bis) bidentate selective high affinity ligands as HLA-DR10 beta antibody mimics targeting non-Hodgkin's lymphoma.
Gerald L DeNardo, Saphon Hok, Arutselvan Van Natarajan, Monique Cosman, Sally J DeNardo

Int J Oncol· October 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthesis and radiolabeling of selective high-affinity ligands designed to target non-Hodgkin's lymphoma and leukemia.
Saphon Hok, Arutselvan Natarajan, Rod Balhorn, Sally J DeNardo, Gerald L DeNardo

Bioconjug Chem· August 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetic characterization in xenografted mice of a series of first-generation mimics for HLA-DR antibody, Lym-1, as carrier molecules to image and treat lymphoma.
Gerald L DeNardo, Arutselvan Natarajan, Saphon Hok, Julie Perkins, Monique Cosman, Sally J DeNardo

J Nucl Med· August 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of antilymphoma antibody, 131I-Lym-1, on peripheral blood lymphocytes in patients with non-Hodgkin's lymphoma.
Orazio Schillaci, Gerald L DeNardo, Sally J DeNardo, Desiree S Goldstein, Linda A Kroger

Cancer Biother Radiopharm· August 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recombinant expression of the beta-subunit of HLA-DR10 for the selection of novel lymphoma targeting molecules.
Huguette Albrecht, Monique Cosman, Maria Ngu-Schwemlein, Michele Corzett, Kena W Curran, Sally J DeNardo, Gerald L DeNardo

Cancer Biother Radiopharm· August 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Selecting an intervention time for intravascular enzymatic cleavage of peptide linkers to clear radioisotope from normal tissues.
Christine L Hartmann Siantar, Gerald L DeNardo, Kit Lam, Aina Yuan, Thomas Daly, Sally J DeNardo

Cancer Biother Radiopharm· August 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combination immunotherapy with anti-CD20 and anti-HLA-DR monoclonal antibodies induces synergistic anti-lymphoma effects in human lymphoma cell lines.
Evan Tobin, Gerald Denardo, Nan Zhang, Alan L Epstein, Cathy Liu, Sally Denardo

Leuk Lymphoma· May 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Thermal dosimetry predictive of efficacy of 111In-ChL6 nanoparticle AMF--induced thermoablative therapy for human breast cancer in mice.
Sally J DeNardo, Gerald L DeNardo, Arutselvan Natarajan, Laird A Miers, Allan R Foreman

J Nucl Med· March 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of tissue plasminogen activator specific "on demand cleavable" (odc) linkers for radioimmunotherapy by screening one-bead-one-compound combinatorial peptide libraries.
Pappanaicken R Kumaresan, Arutselvan Natarajan, Aimin Song, Xiaobing Wang, Ruiwu Liu, Gerald DeNardo, Sally DeNardo

Bioconjug Chem· February 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Construction of di-scFv through a trivalent alkyne-azide 1,3-dipolar cycloaddition.
Arutselvan Natarajan, Wenjun Du, Cheng-Yi Xiong, Gerald L DeNardo, Sally J DeNardo

Chem Commun (Camb)· February 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Direct antilymphoma activity of novel, first-generation "antibody mimics" that bind HLA-DR10-positive non-Hodgkin's lymphoma cells.
Jeremy West, Julie Perkins, Saphon Hok, Rodney Balhorn, Felice C Lightstone, Sally J DeNardo, Gerald L DeNardo

Cancer Biother Radiopharm· December 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis